Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin

BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.

Bibliographic Details
Main Authors: Shaun K Morris, Upton D Allen, Sumit Gupta, Susan E Richardson
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2012/957973
id doaj-f8b7c4e526224fccb165d2307bd315cf
record_format Article
spelling doaj-f8b7c4e526224fccb165d2307bd315cf2021-07-02T02:49:33ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-0123417918210.1155/2012/957973Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving CaspofunginShaun K Morris0Upton D Allen1Sumit Gupta2Susan E Richardson3Division of Infectious Diseases, Toronto, Ontario, CanadaDivision of Infectious Diseases, Toronto, Ontario, CanadaDivision of Haematology and Oncology, Department of Pediatrics, Toronto, Ontario, CanadaDivision of Microbiology, The Hospital for Sick Children, Toronto, Ontario, CanadaBACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.http://dx.doi.org/10.1155/2012/957973
collection DOAJ
language English
format Article
sources DOAJ
author Shaun K Morris
Upton D Allen
Sumit Gupta
Susan E Richardson
spellingShingle Shaun K Morris
Upton D Allen
Sumit Gupta
Susan E Richardson
Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
Canadian Journal of Infectious Diseases and Medical Microbiology
author_facet Shaun K Morris
Upton D Allen
Sumit Gupta
Susan E Richardson
author_sort Shaun K Morris
title Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_short Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_full Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_fullStr Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_full_unstemmed Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
title_sort breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases and Medical Microbiology
issn 1712-9532
publishDate 2012-01-01
description BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.
url http://dx.doi.org/10.1155/2012/957973
work_keys_str_mv AT shaunkmorris breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
AT uptondallen breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
AT sumitgupta breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
AT susanerichardson breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin
_version_ 1721342752796442624